Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

ANKRD10 Inhibitors

The vast world of cellular regulation is populated with a diverse range of proteins, each playing its own unique role in maintaining the intricate balance of cellular processes. Among these, ANKRD10, or Ankyrin Repeat Domain 10, stands as a representative of the ankyrin repeat-containing protein family. These proteins are characterized by the presence of ankyrin repeats, a common protein motif involved in mediating protein-protein interactions. As ANKRD10 engages in its roles within the cellular environment, it becomes a focal point of interest for researchers aiming to modulate its activity, leading to the conceptual development of ANKRD10 inhibitors.

ANKRD10 inhibitors, by definition, are chemical compounds designed to specifically interfere with the function and activity of the ANKRD10 protein. The mechanism by which these inhibitors operate can vary. Some might directly bind to the protein, blocking its active or binding sites and rendering it inactive. Others might target the synthesis, folding, or degradation processes of the protein, thus regulating its abundance within the cell. The challenge with developing specific inhibitors for a protein like ANKRD10 lies in ensuring specificity. Given the widespread occurrence of ankyrin repeats in various proteins, it becomes paramount to design inhibitors that solely target ANKRD10 without inadvertently affecting other proteins of the ankyrin family. The understanding and development of ANKRD10 inhibitors is an evolving field. As science delves deeper into the nuances of cellular regulation and protein interaction networks, the quest for deciphering and modulating the roles of proteins like ANKRD10 becomes an ever-exciting journey in molecular biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cardamonin

19309-14-9sc-293984
sc-293984A
10 mg
50 mg
$224.00
$940.00
(1)

Known to inhibit NF-kappaB, which contains ankyrin repeats. Might influence ANKRD10's interaction or stability.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

Inhibits IkBα, an ankyrin repeat-containing protein. Could have off-target effects on ANKRD10.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

Inhibits NF-kappaB activation. Might affect ANKRD10 indirectly through cellular signaling.

IMD 0354

978-62-1sc-203084
5 mg
$199.00
3
(1)

IKKβ inhibitor affecting NF-kappaB pathway. Potential indirect effects on ANKRD10.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$81.00
$306.00
32
(2)

Known to inhibit NF-kappaB activation. Potential indirect effects on ANKRD10's function or stability.

Wedelolactone

524-12-9sc-200648
sc-200648A
1 mg
5 mg
$110.00
$337.00
8
(0)

Inhibits IKK, affecting NF-kappaB signaling. Might influence ANKRD10 indirectly.

QNZ

545380-34-5sc-200675
1 mg
$117.00
12
(1)

Suppresses NF-kappaB activation. Potential indirect effects on ANKRD10 through cellular signaling pathways.

Tanshinone IIA

568-72-9sc-200932
sc-200932A
5 mg
25 mg
$88.00
$316.00
22
(2)

Known to inhibit NF-kappaB and might affect ANKRD10 indirectly.

Celastrol, Celastrus scandens

34157-83-0sc-202534
10 mg
$158.00
6
(1)

Affects NF-kappaB signaling. Might have indirect effects on ANKRD10.

Caffeic Acid

331-39-5sc-200499
sc-200499A
1 g
5 g
$32.00
$62.00
1
(2)

Inhibits NF-kappaB activation. Potential indirect effects on ANKRD10's function.